BRIDGEBIO PHARMA INC

CUSIP: 10806XAB8 Class: NOTE 2.500% 3/1

MORGAN STANLEY's Holding History (CIK: 0000895421)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 81,000 Value ($000) $114 Avg Close — Range —
Q2 2025
Shares 10,173,000 Value ($000) $12,651 Avg Close — Range —
Q3 2024
Shares 1,562,000 Value ($000) $1,607 Avg Close — Range —
Q2 2024
Shares 2,812,000 Value ($000) $2,826 Avg Close — Range —
Q4 2023
Shares 4,691,000 Value ($000) $5,635 Avg Close — Range —
Q3 2023
Shares 6,532,000 Value ($000) $6,254 Avg Close — Range —
Q2 2023
Shares 3,152,000 Value ($000) $2,435 Avg Close — Range —
Q1 2023
Shares 3,152,000 Value ($000) $2,320 Avg Close — Range —
Q4 2022
Shares 5,290,000 Value ($000) $2,302 Avg Close — Range —
Q3 2022
Shares 5,290,000 Value ($000) $3,003 Avg Close — Range —
Q2 2022
Shares 8,290,000 Value ($000) $4,340 Avg Close — Range —
Q1 2022
Shares 6,190,000 Value ($000) $3,663 Avg Close — Range —
Q4 2021
Shares 7,690,000 Value ($000) $5,421 Avg Close — Range —
Q3 2021
Shares 1,021,000 Value ($000) $1,405 Avg Close — Range —
Q2 2021
Shares 2,000,000 Value ($000) $3,268 Avg Close — Range —
Q1 2021
Shares 3,283,000 Value ($000) $5,448 Avg Close — Range —